Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea B Apolo

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
The Patient|August 28, 2024
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional ThresholdingAndrea B Apolo, Christine Michaels-Igbokwe, Nicholas I Simon, et al.
The Lancet. Oncology|January 15, 2022
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trialDavid Cella, Robert J Motzer, Cristina Suarez, et al.
Urologic Oncology|May 17, 2017
Advances in medical imaging for the diagnosis and management of common genitourinary cancersMohammad H Bagheri, Mark A Ahlman, Liza Lindenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancerArjun V Balar, Andrea B Apolo, Irina Ostrovnaya, et al.
Current Opinion in Oncology|March 20, 2025
Antibody-drug conjugates in rare genitourinary tumors: review and perspectivesAndre R Kydd, Md Shahid Sarwar, Saad Atiq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Quantitative Assessment of Early [<sup>18</sup>F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to BoneStephanie A Harmon, Timothy Perk, Christie Lin, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial CarcinomaWassim Abida, Matthew I Milowsky, Irina Ostrovnaya, et al.
Ocular Immunology and Inflammation|April 24, 2019
Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic MalignanciesCarl W Noble, Sapna S Gangaputra, Ian A Thompson, et al.
Urology|August 18, 2020
Assessing Contemporary Trends in Female Speakership within Urologic OncologyRuchika Talwar, Adrien Bernstein, Amanda Jones, et al.
Clinical Genitourinary Cancer|June 22, 2019
Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate CancerAlison R Roth, Stephanie A Harmon, Timothy G Perk, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
The Patient|August 28, 2024
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional ThresholdingAndrea B Apolo, Christine Michaels-Igbokwe, Nicholas I Simon, et al.
The Lancet. Oncology|January 15, 2022
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trialDavid Cella, Robert J Motzer, Cristina Suarez, et al.
Urologic Oncology|May 17, 2017
Advances in medical imaging for the diagnosis and management of common genitourinary cancersMohammad H Bagheri, Mark A Ahlman, Liza Lindenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancerArjun V Balar, Andrea B Apolo, Irina Ostrovnaya, et al.
Current Opinion in Oncology|March 20, 2025
Antibody-drug conjugates in rare genitourinary tumors: review and perspectivesAndre R Kydd, Md Shahid Sarwar, Saad Atiq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Quantitative Assessment of Early [<sup>18</sup>F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to BoneStephanie A Harmon, Timothy Perk, Christie Lin, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial CarcinomaWassim Abida, Matthew I Milowsky, Irina Ostrovnaya, et al.
Ocular Immunology and Inflammation|April 24, 2019
Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic MalignanciesCarl W Noble, Sapna S Gangaputra, Ian A Thompson, et al.
Urology|August 18, 2020
Assessing Contemporary Trends in Female Speakership within Urologic OncologyRuchika Talwar, Adrien Bernstein, Amanda Jones, et al.
Clinical Genitourinary Cancer|June 22, 2019
Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate CancerAlison R Roth, Stephanie A Harmon, Timothy G Perk, et al.
Pageof 12